Medical Expulsive Therapy for Ureteral Calculi in the Real World: Targeted Education Increases Use and Improves Patient Outcome

Journal of Urology

Volumn 183, Issue 2, 2010, Pages 585-589

  Brede, Christopher ^a   Hollingsworth, John M ^a,b   Faerber, Gary J ^a   Taylor, John Scott ^a   Wolf Jr , J Stuart ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

adrenergic alpha antagonists; calcium channel blockers; emergencies; ureter; ureteral calculi

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DOXAZOSIN; NIFEDIPINE; TAMSULOSIN; TERAZOSIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; EMERGENCY WARD; FEMALE; HEALTH CARE COST; HEALTH EDUCATION; HEALTH MAINTENANCE ORGANIZATION; HEALTH PRACTITIONER; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; URETER STONE;

ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; AGED, 80 AND OVER; COSTS AND COST ANALYSIS; EMERGENCY MEDICINE; FEMALE; HUMANS; MALE; MIDDLE AGED; URETERAL CALCULI; YOUNG ADULT;

EID: 73749085902     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.10.019     Document Type: Article

References (12)

1. Ljunghall S., Lithell H., and Skarfors E. Prevalence of renal stones in 60-year-old men. A 10-year follow-up study of a health survey. BJU 60 (1987) 10
2. Pearle M., Curhan G., and Calhoun E. Urolithiasis. Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (2004), United States Government Printing Office, Washington, D.C 3
3. Pak C.Y. Kidney stones. Lancet 351 (1998) 1797
4. Borghi L., Meschi T., Amato F., et al. Nifedipine and methylprednisolone in facilitating ureteral stone passage: a randomized, double-blind, placebo-controlled study. J Urol 152 (1994) 1095
5. Cooper J.T., Stack G.M., and Cooper T.P. Intensive medical management of ureteral calculi. Urology 56 (2000) 575
6. Porpiglia F., Destefanis P., Fiori C., et al. Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology 56 (2000) 579
7. Bandi G., Best S.L., and Nakada S.Y. Current practice patterns in the management of upper urinary tract calculi in the north central United States. J Endourol 22 (2008) 631
8. Sterrett S.P., Moore N.W., and Nakada S.Y. Emergency room follow-up trends in urolithiasis: single-center report. Urology 73 (2009) 1195
9. Hollingsworth J.M., Davis M.M., West B.T., et al. Trends in medical expulsive therapy use for urinary stone disease in U.S. emergency departments. Urology (2009) Epub ahead of print
10. Hollingsworth J.M., Rogers M.A., Kaufman S.R., et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 368 (2006) 1171
11. Clark J.Y., Thompson I.M., and Optenberg S.A. Economic impact of urolithiasis in the United States. J Urol 154 (1995) 2020
12. Bensalah K., Pearle M., and Lotan Y. Cost-effectiveness of medical expulsive therapy using alpha-blockers for the treatment of distal ureteral stones. Eur Urol 53 (2008) 411